journal article·2019-12-04Open access

Comparative in vitro transportation of pentamidine across the blood-brain barrier using polycaprolactone nanoparticles and phosphatidylcholine liposomes

Geofrey Omarch, Yunus Kippie, Shireen Mentor, Naushaad Ebrahim, David Fisher, Grace Murilla, Hulda Swai, Admire Dube

Abstract

Nanoparticles (NPs) have gained importance in addressing drug delivery challenges across biological barriers. Here, we reformulated pentamidine, a drug used to treat Human African Trypanosomiasis (HAT) in polymer based nanoparticles and liposomes and compared their capability to enhance pentamidine penetration across blood brain barrier (BBB). Size, polydispersity index, zeta potential, morphology, pentamidine loading and drug release profiles were determined by various methods. Cytotoxicity was tested against the immortalized mouse brain endothelioma cells over 96 h. Moreover, cells monolayer integrity and transportation ability were examined for 24 h. Pentamidine-loaded polycaprolactone (PCL) nanoparticles had a mean size of 267.58, PDI of 0.25 and zeta potential of -28.1 mV and pentamidine-loaded liposomes had a mean size of 119.61 nm, PDI of 0.25 and zeta potential 11.78. Pentamidine loading was 0.16 µg/mg (w/w) and 0.17 µg/mg (w/w) in PCL NPs and liposomes respectively. PCL nanoparticles and liposomes released 12.13% and 22.21% of pentamidine respectively after 24 h. Liposomes transported 87% of the dose, PCL NPs 66% of the dose and free pentamidine penetration was 63% of the dose. These results suggest that liposomes are comparatively promising nanocarriers for transportation of pentamidine across BBB.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Lipid Membrane Structure and Behavior · Advanced Drug Delivery Systems · RNA Interference and Gene Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Life Sciences, The Nelson Mandela African Institution of Science and Technology

Tanzania Veterinary Laboratory Agency

School of Pharmacy, University of the Western Cape

School of Life Sciences, University of the Western Cape

Biotechnology Research Institute, Kenya Agricultural and Livestock Research Organization

References (36)

Show source-provided references
1. 10.1016/S0006-2952(00)00477-910.1016/S0006-2952(00)00477-9 ↗
2. 10.1371/journal.pntd.000223010.1371/journal.pntd.0002230 ↗
3. 10.1371/journal.pntd.000545410.1371/journal.pntd.0005454 ↗
4. 10.1371/journal.pntd.000262410.1371/journal.pntd.0002624 ↗
5. 10.1179/2047773213Y.000000010510.1179/2047773213Y.0000000105 ↗
6. 10.1016/j.drup.2003.09.00110.1016/j.drup.2003.09.001 ↗
7. 10.1124/jpet.108.14987210.1124/jpet.108.149872 ↗
8. 10.1046/j.1365-3156.2001.00764.x10.1046/j.1365-3156.2001.00764.x ↗
9. 10.1016/j.jconrel.2014.11.00210.1016/j.jconrel.2014.11.002 ↗
10. 10.1016/S0169-4758(00)01850-010.1016/S0169-4758(00)01850-0 ↗
11. 10.2174/09298671280414326810.2174/092986712804143268 ↗
12. 10.1016/j.pt.2012.12.00510.1016/j.pt.2012.12.005 ↗
13. 10.1080/0148391860807875910.1080/01483918608078759 ↗
14. 10.1017/S003118201300029210.1017/S0031182013000292 ↗
15. 10.1017/S003118201000113710.1017/S0031182010001137 ↗
16. 10.1016/j.biochi.2008.02.01710.1016/j.biochi.2008.02.017 ↗
17. 10.1128/AAC.00225-0910.1128/AAC.00225-09 ↗
18. 10.1002/(SICI)1098-2299(199802)43:2<98::AID-DDR2>3.0.CO;2-K10.1002/(SICI)1098-2299(199802)43:2<98::AID-DDR2>3.0.CO;2-K ↗
19. Dua JS, Rana AC, Bhandari A. K. Review article liposome: methods of preparation and applications. Int J Pharmaceut Stud Res. 2012;III:7.
20. 10.1016/j.jconrel.2004.03.02310.1016/j.jconrel.2004.03.023 ↗
21. 10.4103/0975-1483.10436410.4103/0975-1483.104364 ↗
22. 10.3109/08982104.2011.62751310.3109/08982104.2011.627513 ↗
23. 10.1016/j.jconrel.2017.05.01910.1016/j.jconrel.2017.05.019 ↗
24. 10.1016/j.addr.2006.09.01710.1016/j.addr.2006.09.017 ↗
25. 10.1080/17425247.2017.131626210.1080/17425247.2017.1316262 ↗
26. 10.1517/17425247.2014.95056410.1517/17425247.2014.950564 ↗
27. 10.1016/j.jconrel.2008.09.07310.1016/j.jconrel.2008.09.073 ↗
28. 10.1016/S1359-0286(02)00117-110.1016/S1359-0286(02)00117-1 ↗
29. 10.1080/1061186050007129210.1080/10611860500071292 ↗
30. 10.1016/j.ijpharm.2006.06.02210.1016/j.ijpharm.2006.06.022 ↗
31. 10.1016/j.ejps.2013.02.00610.1016/j.ejps.2013.02.006 ↗
32. 10.1155/2015/69267210.1155/2015/692672 ↗
33. 10.1016/j.ijpharm.2009.09.02310.1016/j.ijpharm.2009.09.023 ↗
34. 10.1007/s00396-014-3464-910.1007/s00396-014-3464-9 ↗
35. 10.1016/j.colsurfb.2004.09.00410.1016/j.colsurfb.2004.09.004 ↗
36. 10.1177/221106821456102510.1177/2211068214561025 ↗